"Our dermatologists are Board certified by the American Board of Dermatology and are award-winning leaders in the field. We are the largest users of botulinum and fillers in the mid-atlantic region. We are leaders in lasers and energy device treatments, offering dozens of types of treatments for clearer skin, most of which we helped to develop. Our facility has over 45 devices on its premises. We also specialize in medical dermatology."

During the past decade, Maryland Laser Skin and Vein Institute conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 11 clinical trials were completed, i.e. on average, 57.9% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 9 clinical trials were completed. i.e. 112.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Maryland Laser Skin and Vein Institute" #1 sponsor was "Galderma R&D" with 4 trials, followed by "Cynosure, Inc." with 3 trials sponsored, "BTL Industries Ltd." with 2 trials sponsored, "Cassiopea SpA" with 2 trials sponsored and "Medtronic Endovascular" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maryland Laser Skin and Vein Institute" #1 collaborator was "Q-Med Scandinavia, Inc." with 1 trials as a collaborator, "Sapheon, Inc." with 1 trials as a collaborator, "Syneron Medical" with 1 trials as a collaborator and "Ulthera, Inc" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Maryland Laser Skin and Vein Institute" are "Acne Vulgaris" (2 trials), "Great Saphenous Vein (GSV) With Venous Reflux Disease" (2 trials), "Lateral Canthal Lines" (2 trials), "Acne" (1 trials) and "Acne Scarring of the Face" (1 trials). Many other conditions were trialed in "Maryland Laser Skin and Vein Institute" in a lesser frequency.

Most popular intervention types in "Maryland Laser Skin and Vein Institute" are "Device" (20 trials), "Drug" (8 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "BTL-899" (2 trials), "CB-03-01 cream, 1%" (2 trials), "ClosureFast Radiofrequency Ablation (RFA)" (2 trials) and "MT10109L" (2 trials). Other intervention names were less common.

The vast majority of trials in "Maryland Laser Skin and Vein Institute" are 28 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Maryland Laser Skin and Vein Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Maryland Laser Skin and Vein Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Maryland Laser Skin and Vein Institute, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 17 trials that are defined as “Not Applicable".